Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01274390 · ClinicalTrials.gov registry record
Impact of Blood Storage Duration on Physiologic Measures
A clinical trial of Cardiac Surgery and Erythrocyte Transfusion, sponsored by Duke University.
- Completed
- Registry status
- 390
- Enrollment target
- 4
- Study locations
NCT01274390: Completed study of Cardiac Surgery and Erythrocyte Transfusion, sponsored by Duke University.
NCT01274390 is a study of Cardiac Surgery and Erythrocyte Transfusion that has completed, run by Duke University. The registered enrollment target is 390 participants, below the 725-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (46% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01274390, a study of Cardiac Surgery and Erythrocyte Transfusion, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red blood cell units stored for at least 21 days, if they need any red blood cell transfusions during their hospital stay for the surgery. This ancillary study is entitled Impact of Blood Storage Duration on Physiologic Measures: RECESS Ancillary Physiologic Study (RECAP). The hypothesis of the RECAP study is that there will be differences between the two randomized treatment groups in how much the following measurements change, from shortly before a red blood cell transfusion to shortly after a red blood cell transfusion, and from before surgery to 24 hours after surgery: * Oxygen saturation in the hand * Oxygen saturation in the brain * Blood flow in the small blood vessels under the tongue. The RECAP study will also investigate whether changes in the measurements listed above are associated with clinical outcomes, including * The Multi-Organ Dysfunction Score * Death from any cause * Major cardiac events * Major pulmonary events
Conditions Studied
Study Locations (4)
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Womens Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-01 |
What the finished NCT01274390 record still lists
NCT01274390 is an observational study that tracks outcomes without assigning an intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 725-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (46% lower).
The record links to 2 conditions, with Cardiac Surgery appearing as the primary indexed condition, and to 0 interventions.
NCT01274390 reports a single indexed study location in Massachusetts, Minnesota, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01274390 about?
NCT01274390 is a clinical study titled "Impact of Blood Storage Duration on Physiologic Measures". This study is an ancillary (add-on) study to the clinical trial entitled Red Cell Storage Duration Study (RECESS), which has clinicaltrials.gov identifier NCT00991341. The RECESS study randomizes cardiac surgery patients to receive either red blood cell units stored for no more than 10 days, or red ...
What is the current status of trial NCT01274390?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2011-01. Estimated completion is 2014-01.
What conditions does trial NCT01274390 study?
This clinical trial studies the following conditions: Cardiac Surgery, Erythrocyte Transfusion.
Who is sponsoring clinical trial NCT01274390?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01274390 being conducted?
This trial has 4 study locations across Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01274390's enrollment target sits among peer trials
390 5th of 19 higher than 15 of 19 other Cardiac Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
RECRUITING · NA
-
Oral Methadone in Cardiac Surgery
RECRUITING · Phase 4
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery
RECRUITING · Early Phase 1
-
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia